Global mRNA COVID-19 Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
The Global mRNA COVID-19 Vaccine Market Size was estimated at USD 4108.63 million in 2023 and is projected to reach USD 4439.70 million by 2029, exhibiting a CAGR of 1.30% during the forecast period.
This report provides a deep insight into the global mRNA COVID-19 Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA COVID-19 Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA COVID-19 Vaccine market in any manner.
Global mRNA COVID-19 Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Market Segmentation (by Type)
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Market Segmentation (by Application)
Children
Adults
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA COVID-19 Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
The Global mRNA COVID-19 Vaccine Market Size was estimated at USD 4108.63 million in 2023 and is projected to reach USD 4439.70 million by 2029, exhibiting a CAGR of 1.30% during the forecast period.
This report provides a deep insight into the global mRNA COVID-19 Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA COVID-19 Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA COVID-19 Vaccine market in any manner.
Global mRNA COVID-19 Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Market Segmentation (by Type)
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Market Segmentation (by Application)
Children
Adults
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the mRNA COVID-19 Vaccine Market
- Overview of the regional outlook of the mRNA COVID-19 Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA COVID-19 Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA COVID-19 Vaccine
1.2 Key Market Segments
1.2.1 mRNA COVID-19 Vaccine Segment by Type
1.2.2 mRNA COVID-19 Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA COVID-19 VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA COVID-19 Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA COVID-19 Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA COVID-19 VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global mRNA COVID-19 Vaccine Sales by Manufacturers (2019-2024)
3.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA COVID-19 Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA COVID-19 Vaccine Sales Sites, Area Served, Product Type
3.6 mRNA COVID-19 Vaccine Market Competitive Situation and Trends
3.6.1 mRNA COVID-19 Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA COVID-19 Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRNA COVID-19 VACCINE INDUSTRY CHAIN ANALYSIS
4.1 mRNA COVID-19 Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA COVID-19 VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRNA COVID-19 VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2019-2024)
6.3 Global mRNA COVID-19 Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global mRNA COVID-19 Vaccine Price by Type (2019-2024)
7 MRNA COVID-19 VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA COVID-19 Vaccine Market Sales by Application (2019-2024)
7.3 Global mRNA COVID-19 Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA COVID-19 Vaccine Sales Growth Rate by Application (2019-2024)
8 MRNA COVID-19 VACCINE MARKET SEGMENTATION BY REGION
8.1 Global mRNA COVID-19 Vaccine Sales by Region
8.1.1 Global mRNA COVID-19 Vaccine Sales by Region
8.1.2 Global mRNA COVID-19 Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA COVID-19 Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA COVID-19 Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA COVID-19 Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA COVID-19 Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA COVID-19 Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Moderna
9.1.1 Moderna mRNA COVID-19 Vaccine Basic Information
9.1.2 Moderna mRNA COVID-19 Vaccine Product Overview
9.1.3 Moderna mRNA COVID-19 Vaccine Product Market Performance
9.1.4 Moderna Business Overview
9.1.5 Moderna mRNA COVID-19 Vaccine SWOT Analysis
9.1.6 Moderna Recent Developments
9.2 CanSino Biologicals
9.2.1 CanSino Biologicals mRNA COVID-19 Vaccine Basic Information
9.2.2 CanSino Biologicals mRNA COVID-19 Vaccine Product Overview
9.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Product Market Performance
9.2.4 CanSino Biologicals Business Overview
9.2.5 CanSino Biologicals mRNA COVID-19 Vaccine SWOT Analysis
9.2.6 CanSino Biologicals Recent Developments
9.3 Pfizer
9.3.1 Pfizer mRNA COVID-19 Vaccine Basic Information
9.3.2 Pfizer mRNA COVID-19 Vaccine Product Overview
9.3.3 Pfizer mRNA COVID-19 Vaccine Product Market Performance
9.3.4 Pfizer mRNA COVID-19 Vaccine SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Fosun-Pharmaceutical
9.4.1 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Basic Information
9.4.2 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Overview
9.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Market Performance
9.4.4 Fosun-Pharmaceutical Business Overview
9.4.5 Fosun-Pharmaceutical Recent Developments
9.5 CSPC Pharmaceutical
9.5.1 CSPC Pharmaceutical mRNA COVID-19 Vaccine Basic Information
9.5.2 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Overview
9.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Market Performance
9.5.4 CSPC Pharmaceutical Business Overview
9.5.5 CSPC Pharmaceutical Recent Developments
10 MRNA COVID-19 VACCINE MARKET FORECAST BY REGION
10.1 Global mRNA COVID-19 Vaccine Market Size Forecast
10.2 Global mRNA COVID-19 Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA COVID-19 Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific mRNA COVID-19 Vaccine Market Size Forecast by Region
10.2.4 South America mRNA COVID-19 Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA COVID-19 Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global mRNA COVID-19 Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA COVID-19 Vaccine by Type (2025-2030)
11.1.2 Global mRNA COVID-19 Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA COVID-19 Vaccine by Type (2025-2030)
11.2 Global mRNA COVID-19 Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global mRNA COVID-19 Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA COVID-19 Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA COVID-19 Vaccine
1.2 Key Market Segments
1.2.1 mRNA COVID-19 Vaccine Segment by Type
1.2.2 mRNA COVID-19 Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA COVID-19 VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA COVID-19 Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA COVID-19 Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA COVID-19 VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global mRNA COVID-19 Vaccine Sales by Manufacturers (2019-2024)
3.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA COVID-19 Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA COVID-19 Vaccine Sales Sites, Area Served, Product Type
3.6 mRNA COVID-19 Vaccine Market Competitive Situation and Trends
3.6.1 mRNA COVID-19 Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA COVID-19 Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRNA COVID-19 VACCINE INDUSTRY CHAIN ANALYSIS
4.1 mRNA COVID-19 Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA COVID-19 VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRNA COVID-19 VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2019-2024)
6.3 Global mRNA COVID-19 Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global mRNA COVID-19 Vaccine Price by Type (2019-2024)
7 MRNA COVID-19 VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA COVID-19 Vaccine Market Sales by Application (2019-2024)
7.3 Global mRNA COVID-19 Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA COVID-19 Vaccine Sales Growth Rate by Application (2019-2024)
8 MRNA COVID-19 VACCINE MARKET SEGMENTATION BY REGION
8.1 Global mRNA COVID-19 Vaccine Sales by Region
8.1.1 Global mRNA COVID-19 Vaccine Sales by Region
8.1.2 Global mRNA COVID-19 Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA COVID-19 Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA COVID-19 Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA COVID-19 Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA COVID-19 Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA COVID-19 Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Moderna
9.1.1 Moderna mRNA COVID-19 Vaccine Basic Information
9.1.2 Moderna mRNA COVID-19 Vaccine Product Overview
9.1.3 Moderna mRNA COVID-19 Vaccine Product Market Performance
9.1.4 Moderna Business Overview
9.1.5 Moderna mRNA COVID-19 Vaccine SWOT Analysis
9.1.6 Moderna Recent Developments
9.2 CanSino Biologicals
9.2.1 CanSino Biologicals mRNA COVID-19 Vaccine Basic Information
9.2.2 CanSino Biologicals mRNA COVID-19 Vaccine Product Overview
9.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Product Market Performance
9.2.4 CanSino Biologicals Business Overview
9.2.5 CanSino Biologicals mRNA COVID-19 Vaccine SWOT Analysis
9.2.6 CanSino Biologicals Recent Developments
9.3 Pfizer
9.3.1 Pfizer mRNA COVID-19 Vaccine Basic Information
9.3.2 Pfizer mRNA COVID-19 Vaccine Product Overview
9.3.3 Pfizer mRNA COVID-19 Vaccine Product Market Performance
9.3.4 Pfizer mRNA COVID-19 Vaccine SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Fosun-Pharmaceutical
9.4.1 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Basic Information
9.4.2 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Overview
9.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Market Performance
9.4.4 Fosun-Pharmaceutical Business Overview
9.4.5 Fosun-Pharmaceutical Recent Developments
9.5 CSPC Pharmaceutical
9.5.1 CSPC Pharmaceutical mRNA COVID-19 Vaccine Basic Information
9.5.2 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Overview
9.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Market Performance
9.5.4 CSPC Pharmaceutical Business Overview
9.5.5 CSPC Pharmaceutical Recent Developments
10 MRNA COVID-19 VACCINE MARKET FORECAST BY REGION
10.1 Global mRNA COVID-19 Vaccine Market Size Forecast
10.2 Global mRNA COVID-19 Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA COVID-19 Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific mRNA COVID-19 Vaccine Market Size Forecast by Region
10.2.4 South America mRNA COVID-19 Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA COVID-19 Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global mRNA COVID-19 Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA COVID-19 Vaccine by Type (2025-2030)
11.1.2 Global mRNA COVID-19 Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA COVID-19 Vaccine by Type (2025-2030)
11.2 Global mRNA COVID-19 Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global mRNA COVID-19 Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA COVID-19 Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA COVID-19 Vaccine Market Size Comparison by Region (M USD)
Table 5. Global mRNA COVID-19 Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA COVID-19 Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA COVID-19 Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA COVID-19 Vaccine as of 2022)
Table 10. Global Market mRNA COVID-19 Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA COVID-19 Vaccine Sales Sites and Area Served
Table 12. Manufacturers mRNA COVID-19 Vaccine Product Type
Table 13. Global mRNA COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA COVID-19 Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA COVID-19 Vaccine Market Challenges
Table 22. Global mRNA COVID-19 Vaccine Sales by Type (Kilotons)
Table 23. Global mRNA COVID-19 Vaccine Market Size by Type (M USD)
Table 24. Global mRNA COVID-19 Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global mRNA COVID-19 Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA COVID-19 Vaccine Market Size Share by Type (2019-2024)
Table 28. Global mRNA COVID-19 Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global mRNA COVID-19 Vaccine Sales (Kilotons) by Application
Table 30. Global mRNA COVID-19 Vaccine Market Size by Application
Table 31. Global mRNA COVID-19 Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global mRNA COVID-19 Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA COVID-19 Vaccine Market Share by Application (2019-2024)
Table 35. Global mRNA COVID-19 Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA COVID-19 Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America mRNA COVID-19 Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe mRNA COVID-19 Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific mRNA COVID-19 Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America mRNA COVID-19 Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa mRNA COVID-19 Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Moderna mRNA COVID-19 Vaccine Basic Information
Table 44. Moderna mRNA COVID-19 Vaccine Product Overview
Table 45. Moderna mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Moderna Business Overview
Table 47. Moderna mRNA COVID-19 Vaccine SWOT Analysis
Table 48. Moderna Recent Developments
Table 49. CanSino Biologicals mRNA COVID-19 Vaccine Basic Information
Table 50. CanSino Biologicals mRNA COVID-19 Vaccine Product Overview
Table 51. CanSino Biologicals mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CanSino Biologicals Business Overview
Table 53. CanSino Biologicals mRNA COVID-19 Vaccine SWOT Analysis
Table 54. CanSino Biologicals Recent Developments
Table 55. Pfizer mRNA COVID-19 Vaccine Basic Information
Table 56. Pfizer mRNA COVID-19 Vaccine Product Overview
Table 57. Pfizer mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer mRNA COVID-19 Vaccine SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Basic Information
Table 62. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Overview
Table 63. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Fosun-Pharmaceutical Business Overview
Table 65. Fosun-Pharmaceutical Recent Developments
Table 66. CSPC Pharmaceutical mRNA COVID-19 Vaccine Basic Information
Table 67. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Overview
Table 68. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CSPC Pharmaceutical Business Overview
Table 70. CSPC Pharmaceutical Recent Developments
Table 71. Global mRNA COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global mRNA COVID-19 Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America mRNA COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe mRNA COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific mRNA COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific mRNA COVID-19 Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America mRNA COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa mRNA COVID-19 Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global mRNA COVID-19 Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global mRNA COVID-19 Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global mRNA COVID-19 Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global mRNA COVID-19 Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global mRNA COVID-19 Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA COVID-19 Vaccine Market Size Comparison by Region (M USD)
Table 5. Global mRNA COVID-19 Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA COVID-19 Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA COVID-19 Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA COVID-19 Vaccine as of 2022)
Table 10. Global Market mRNA COVID-19 Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA COVID-19 Vaccine Sales Sites and Area Served
Table 12. Manufacturers mRNA COVID-19 Vaccine Product Type
Table 13. Global mRNA COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA COVID-19 Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA COVID-19 Vaccine Market Challenges
Table 22. Global mRNA COVID-19 Vaccine Sales by Type (Kilotons)
Table 23. Global mRNA COVID-19 Vaccine Market Size by Type (M USD)
Table 24. Global mRNA COVID-19 Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global mRNA COVID-19 Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA COVID-19 Vaccine Market Size Share by Type (2019-2024)
Table 28. Global mRNA COVID-19 Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global mRNA COVID-19 Vaccine Sales (Kilotons) by Application
Table 30. Global mRNA COVID-19 Vaccine Market Size by Application
Table 31. Global mRNA COVID-19 Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global mRNA COVID-19 Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA COVID-19 Vaccine Market Share by Application (2019-2024)
Table 35. Global mRNA COVID-19 Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA COVID-19 Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America mRNA COVID-19 Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe mRNA COVID-19 Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific mRNA COVID-19 Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America mRNA COVID-19 Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa mRNA COVID-19 Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Moderna mRNA COVID-19 Vaccine Basic Information
Table 44. Moderna mRNA COVID-19 Vaccine Product Overview
Table 45. Moderna mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Moderna Business Overview
Table 47. Moderna mRNA COVID-19 Vaccine SWOT Analysis
Table 48. Moderna Recent Developments
Table 49. CanSino Biologicals mRNA COVID-19 Vaccine Basic Information
Table 50. CanSino Biologicals mRNA COVID-19 Vaccine Product Overview
Table 51. CanSino Biologicals mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CanSino Biologicals Business Overview
Table 53. CanSino Biologicals mRNA COVID-19 Vaccine SWOT Analysis
Table 54. CanSino Biologicals Recent Developments
Table 55. Pfizer mRNA COVID-19 Vaccine Basic Information
Table 56. Pfizer mRNA COVID-19 Vaccine Product Overview
Table 57. Pfizer mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer mRNA COVID-19 Vaccine SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Basic Information
Table 62. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Overview
Table 63. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Fosun-Pharmaceutical Business Overview
Table 65. Fosun-Pharmaceutical Recent Developments
Table 66. CSPC Pharmaceutical mRNA COVID-19 Vaccine Basic Information
Table 67. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Overview
Table 68. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CSPC Pharmaceutical Business Overview
Table 70. CSPC Pharmaceutical Recent Developments
Table 71. Global mRNA COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global mRNA COVID-19 Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America mRNA COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe mRNA COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific mRNA COVID-19 Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific mRNA COVID-19 Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America mRNA COVID-19 Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa mRNA COVID-19 Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa mRNA COVID-19 Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global mRNA COVID-19 Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global mRNA COVID-19 Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global mRNA COVID-19 Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global mRNA COVID-19 Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global mRNA COVID-19 Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA COVID-19 Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA COVID-19 Vaccine Market Size (M USD), 2019-2030
Figure 5. Global mRNA COVID-19 Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global mRNA COVID-19 Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA COVID-19 Vaccine Market Size by Country (M USD)
Figure 11. mRNA COVID-19 Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global mRNA COVID-19 Vaccine Revenue Share by Manufacturers in 2023
Figure 13. mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA COVID-19 Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA COVID-19 Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA COVID-19 Vaccine Market Share by Type
Figure 18. Sales Market Share of mRNA COVID-19 Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of mRNA COVID-19 Vaccine by Type in 2023
Figure 20. Market Size Share of mRNA COVID-19 Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA COVID-19 Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA COVID-19 Vaccine Market Share by Application
Figure 24. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA COVID-19 Vaccine Sales Market Share by Application in 2023
Figure 26. Global mRNA COVID-19 Vaccine Market Share by Application (2019-2024)
Figure 27. Global mRNA COVID-19 Vaccine Market Share by Application in 2023
Figure 28. Global mRNA COVID-19 Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America mRNA COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada mRNA COVID-19 Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA COVID-19 Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe mRNA COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 37. Germany mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific mRNA COVID-19 Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific mRNA COVID-19 Vaccine Sales Market Share by Region in 2023
Figure 44. China mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America mRNA COVID-19 Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America mRNA COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa mRNA COVID-19 Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa mRNA COVID-19 Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global mRNA COVID-19 Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global mRNA COVID-19 Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global mRNA COVID-19 Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global mRNA COVID-19 Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global mRNA COVID-19 Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of mRNA COVID-19 Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA COVID-19 Vaccine Market Size (M USD), 2019-2030
Figure 5. Global mRNA COVID-19 Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global mRNA COVID-19 Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA COVID-19 Vaccine Market Size by Country (M USD)
Figure 11. mRNA COVID-19 Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global mRNA COVID-19 Vaccine Revenue Share by Manufacturers in 2023
Figure 13. mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA COVID-19 Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA COVID-19 Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA COVID-19 Vaccine Market Share by Type
Figure 18. Sales Market Share of mRNA COVID-19 Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of mRNA COVID-19 Vaccine by Type in 2023
Figure 20. Market Size Share of mRNA COVID-19 Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA COVID-19 Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA COVID-19 Vaccine Market Share by Application
Figure 24. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA COVID-19 Vaccine Sales Market Share by Application in 2023
Figure 26. Global mRNA COVID-19 Vaccine Market Share by Application (2019-2024)
Figure 27. Global mRNA COVID-19 Vaccine Market Share by Application in 2023
Figure 28. Global mRNA COVID-19 Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America mRNA COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada mRNA COVID-19 Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA COVID-19 Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe mRNA COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 37. Germany mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific mRNA COVID-19 Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific mRNA COVID-19 Vaccine Sales Market Share by Region in 2023
Figure 44. China mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America mRNA COVID-19 Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America mRNA COVID-19 Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa mRNA COVID-19 Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa mRNA COVID-19 Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa mRNA COVID-19 Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global mRNA COVID-19 Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global mRNA COVID-19 Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global mRNA COVID-19 Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global mRNA COVID-19 Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global mRNA COVID-19 Vaccine Market Share Forecast by Application (2025-2030)
